Galmed Pharmaceuticals Ltd. Stock Prediction
AI-powered sentiment analysis and prediction trends for GLMD, updated each market day.
GLMD AI Sentiment
AI sees no strong directional signal for Galmed Pharmaceuticals Ltd. stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
Exchange
Market Cap
$4,484,562
Cap Tier
Employees
6
Listed Since
March 13, 2014
Website
GLMD Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
GLMD Volatility
Galmed Pharmaceuticals Ltd. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
